2007 to 2019 saw increase in inflation-adjusted healthcare spending
May 29, 2024
From 2007 to 2019, the medical burden increased from 23.5 to 26.4% for low-income families and from 5.4 to 6.5% for higher-income families.
Prevalence of cardiovascular risk factors, diseases set to increase
Jun 06, 2024
The annual inflation-adjusted health care costs of cardiovascular risk factors is projected to triple between 2020 and 2050.
Sociodemographics tied to rehab use during critical illness hospitalization
May 10, 2024
Dual Medicare and Medicaid eligibility and rural residence were linked to lower odds of physical and occupational therapy receipt.
FDA rescinds ban on Juul e-cigarettes
Jun 07, 2024
The agency said it needs to review both new court decisions and updated data from the vape maker. While the company’s e-cigarettes are back under review, they have not been fully cleared for sale...
9.6 percent of medical visits took place via telehealth in 2021
Jun 03, 2024
The percentage of telehealth visits was higher for mental health than other clinicians.
Distribution pattern of cerebral aneurysms has remained consistent since 1761
Jun 03, 2024
Most cerebral aneurysms occur in the internal carotid, middle cerebral and anterior communicating artery complex regions.
Race-neutral metrics more accurately predict risk in COPD
May 31, 2024
The GLI-Global differentiated all-cause mortality risk between normal spirometry and first grade of COPD in adjusted analyses.
Semaglutide cuts risk for kidney outcomes, death in CKD with T2DM
May 31, 2024
A reduction was seen in risk for clinically important kidney outcomes and death from cardiovascular causes.
Chemo + breast cancer combo accelerates functional decline in seniors
May 29, 2024
The findings compared older adults with breast cancer not receiving chemotherapy and older adults without breast cancer.
Statins reduce CVD risk in adults aged 75 to 85 and 85 years and older
May 28, 2024
A risk reduction was seen for overall cardiovascular disease incidence for initiating statin therapy in both intention-to-treat and per-protocol analyses.